Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

General Biologicals Corp. (4117) Income Statement

General Biologicals Corp. Income Statement

Last quarter (Q2 2026), General Biologicals Corp.'s total revenue was NT$155.22M, an increase of 39.49% from the same quarter last year. In Q2, General Biologicals Corp.'s net income was NT$-75.65M. See General Biologicals Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 215.74MNT$ 251.93MNT$ 264.82MNT$ 370.46MNT$ 551.66M
NT$ 59.62MNT$ 7.54MNT$ 62.71MNT$ 171.85MNT$ 281.94M
NT$ 277.98MNT$ 220.68MNT$ 232.64MNT$ 212.72MNT$ 238.14M
Depreciation and AmortizationNT$ 79.07MNT$ 38.03MNT$ 36.68MNT$ 35.92MNT$ 35.73M
NT$ 604.30MNT$ -170.71MNT$ -139.06MNT$ 7.99MNT$ 85.34M
NT$ -218.37MNT$ -213.14MNT$ -169.94MNT$ -40.87MNT$ 43.79M
NT$ 723.88MNT$ -8.97MNT$ -17.78MNT$ -5.26MNT$ -5.19M
NT$ 505.51MNT$ -222.11MNT$ -187.72MNT$ -46.13MNT$ 38.61M
NT$ 465.84MNT$ -220.82MNT$ -198.83MNT$ -53.19MNT$ 44.14M
Per Share Metrics
Basic EPSNT$ 7.79NT$ -3.69NT$ -3.32NT$ -0.89NT$ 0.74
Diluted EPSNT$ 7.79NT$ -3.69NT$ -3.32NT$ -0.89NT$ 0.74
Weighted Average Shares Outstanding59.83M59.83M59.83M59.83M59.83M
Weighted Average Shares Outstanding (Diluted)59.83M59.83M59.83M59.83M59.91M

Currency in TWD

General Biologicals Corp. Earnings and Revenue History

-300M0300M600M-120 %0 %120 %240 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin